Jeffrey H. Buchalter

2006

In 2006, Jeffrey H. Buchalter earned a total compensation of $3.8M as Chairman of the Board, President and Chief Executive Officer at Enzon Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$1,050,000
Option Awards$1,385,352
Salary$672,115
Stock Awards$624,094
Other$72,145
Total$3,803,706

Buchalter received $1.4M in option awards, accounting for 36% of the total pay in 2006.

Buchalter also received $1.1M in non-equity incentive plan, $672.1K in salary, $624.1K in stock awards and $72.1K in other compensation.

Rankings

In 2006, Jeffrey H. Buchalter's compensation ranked 843rd out of 7,022 executives tracked by ExecPay. In other words, Buchalter earned more than 88.0% of executives.

ClassificationRankingPercentile
All
843
out of 7,022
88th
Division
Manufacturing
261
out of 2,413
89th
Major group
Chemicals And Allied Products
47
out of 673
93rd
Industry group
Drugs
28
out of 518
95th
Industry
Biological Products, Except Diagnostic Substances
4
out of 112
96th
Source: SEC filing on April 16, 2008.

Buchalter's colleagues

We found four more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2006.

2006

Ivan Horak

Enzon Pharmaceuticals

Chief Scientific Officer

2006

Craig Tooman

Enzon Pharmaceuticals

Chief Financial Officer

2006

Ralph del Campo

Enzon Pharmaceuticals

Executive Vice President, Technical Operations

2006

Paul Davit

Enzon Pharmaceuticals

Executive Vice President, Human Resources

You may also like